MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
1.370
-0.010 (-0.72%)
At close: Dec 5, 2025, 4:00 PM EST
1.420
+0.050 (3.65%)
After-hours: Dec 5, 2025, 5:38 PM EST
MacroGenics Stock Forecast
Stock Price Forecast
The 5 analysts that cover MacroGenics stock have a consensus rating of "Hold" and an average price target of $3.20, which forecasts a 133.58% increase in the stock price over the next year. The lowest target is $2.00 and the highest is $5.00.
Price Target: $3.20 (+133.58%)
Analyst Consensus: Hold
* Price targets were last updated on Nov 3, 2025.
Analyst Ratings
The average analyst rating for MacroGenics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 7 | 7 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $2 | Hold | Reiterates | $2 | +45.99% | Nov 3, 2025 |
| Barclays | Barclays | Buy Initiates $3 | Buy | Initiates | $3 | +118.98% | Sep 17, 2025 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +118.98% | May 20, 2025 |
| Stifel | Stifel | Hold Maintains $6 → $5 | Hold | Maintains | $6 → $5 | +264.96% | May 14, 2025 |
| Barclays | Barclays | Buy Maintains $8 → $3 | Buy | Maintains | $8 → $3 | +118.98% | May 14, 2025 |
Financial Forecast
Revenue This Year
127.68M
from 149.96M
Decreased by -14.86%
Revenue Next Year
62.88M
from 127.68M
Decreased by -50.75%
EPS This Year
-1.23
from -1.07
EPS Next Year
-1.87
from -1.23
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 152.8M | 122.4M | ||||
| Avg | 127.7M | 62.9M | ||||
| Low | 105.8M | 10.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.9% | -4.1% | ||||
| Avg | -14.9% | -50.7% | ||||
| Low | -29.4% | -91.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.06 | -0.78 | ||||
| Avg | -1.23 | -1.87 | ||||
| Low | -1.47 | -2.65 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.